Wednesday, July 8, 2026

Intelligence · Clinical Development

Pipeline search results

Programs matching “healthy” across our ClinicalTrials.gov index — phase, modality, sponsor, and trial IDs.

Matching programs 1,124
Total indexed 20,548
Sponsors 1,769

Quick answer

Showing 1,124 pipeline programs matching "healthy" from NovaPharmaNews Clinical Development Intelligence — phase, modality, sponsor, and ClinicalTrials.gov trial IDs.

Refine search

1,124 results for “healthy” Back to intelligence hub

Search results

Page 13 of 47
  1. Buprenorphine

    Teva Pharma GmbH

    Healthy

    phase 1 small molecule completed

    1 trial
  2. Buprenorphine Injectable Solution - Part A

    Indivior Pty Ltd

    Healthy

    phase 1 small molecule completed

    1 trial
  3. Buprenorphine/Naloxone + BEM/RZR

    Atea Pharmaceuticals

    Healthy Volunteer Study

    phase 1 small molecule active

    1 trial
  4. CBP-174

    S.L

    Healthy Adult Subjects

    phase 1 small molecule completed

    1 trial
  5. CBP-201-CN004

    S.L

    Healthy Adult Subjects

    phase 1 mab completed

    1 trial
  6. CBP-307

    S.L

    Healthy Adult Subjects

    phase 1 small molecule completed

    1 trial
  7. CBT124

    Cipla (EU) Limited

    Healthy

    phase 1 mab active

    1 trial
  8. CHE24001

    Lacuna Pharma Pty Ltd

    No therapeutic indication in the current trial with healthy volunteers.

    phase 1 other active

    1 trial
  9. CHS-1701

    Coherus Oncology

    Healthy

    phase 1 small molecule completed

    1 trial
  10. CIM24001

    Lacuna Pharma Pty Ltd

    No therapeutic indication in the current trial with healthy volunteers.

    phase 1 other active

    1 trial
  11. CLI-06001AA1-14

    Chiesi Farmaceutici S.p.A

    This study is a phase I trial to investigate the effect of inhibition of CYP3A4/5 by Erythromycin on the pharmacokinetics of CHF6001 in healthy volunteers.

    phase 1 other active

    1 trial
  12. CLP22001

    Alphapharm Pty Ltd

    Bioequivalence trial in healthy volunteers

    phase 1 other active

    1 trial
  13. CLP24001

    Alphapharm Pty Ltd

    Bioequivalence trial in healthy volunteers

    phase 1 other active

    1 trial
  14. CLTP001A12101

    Novartis Pharmaceuticals

    Healthy volunteers

    phase 1 other active

    1 trial
  15. CMP-CPS-001

    Camp4 Therapeutics Corp

    Healthy Volunteers

    phase 1 small molecule active

    1 trial
  16. CMX001

    Jazz Pharmaceuticals Ireland Limited

    Healthy

    phase 1 small molecule completed

    1 trial
  17. CMX157

    Jazz Pharmaceuticals Ireland Limited

    Healthy

    phase 1 small molecule completed

    1 trial
  18. COR1389-101

    Lacuna Pharma Pty Ltd

    Obesity / Right heart failure (healthy participants)

    phase 1 other active

    1 trial
  19. CORT113176

    CORCEPT THERAPEUTICS INC

    Healthy Adults

    phase 1 small molecule completed

    1 trial
  20. CORT113176 Lipid Capsule Formulation

    CORCEPT THERAPEUTICS INC

    Healthy Adults

    phase 1 small molecule completed

    1 trial
  21. CORT118335 Oral

    CORCEPT THERAPEUTICS INC

    Healthy

    phase 1 small molecule completed

    1 trial
  22. CORT118335, 25 mg

    CORCEPT THERAPEUTICS INC

    Healthy

    phase 1 small molecule completed

    1 trial
  23. CORT125134

    CORCEPT THERAPEUTICS INC

    Healthy

    phase 1 small molecule completed

    2 trials
  24. CORT125134 150 mg

    CORCEPT THERAPEUTICS INC

    Healthy

    phase 1 small molecule completed

    1 trial

Frequently asked questions

What is the Clinical Development Intelligence Platform?

It is NovaPharmaNews pipeline intelligence hub covering 20,548 clinical development programs — not just a directory. It includes phase distribution dashboards, therapeutic area overviews, NDA/BLA watchlists, upcoming readouts, company pipeline rankings, competitive landscape maps, and personalized watchlists.

How does this compare to Evaluate Pharma or Citeline?

Like Evaluate Pharma and Citeline Trialtrove, we index ClinicalTrials.gov programs by sponsor, phase, and indication. Our platform adds cross-links to NovaPharmaNews company profiles, drug INN pages, patents, and congress readout calendars — improving crawl depth and reducing orphan program pages.

Where does pipeline data come from?

Program records derive from ClinicalTrials.gov and link to sponsor company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment decisions. See our data sources page for attribution.

Can I follow a company or program for updates?

Yes — use the watchlist forms on this page to follow sponsors, individual programs, disease clusters, or therapeutic areas. Alerts use the same subscription infrastructure as our events intelligence hub.